Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J van Diest

Showing results (1-10 of 557) with videos related to

Pageof 56
Sort By:
BMJ (Clinical Research Ed.)|September 21, 2002
No consent should be needed for using leftover body material for scientific purposes. ForPaul J van Diest
The American Journal of Surgical Pathology|January 13, 2015
Brief fixation and hormone receptor expression in breast cancer: authors' replyShona Kalkman, Paul J van Diest
Journal of the National Cancer Institute|March 17, 2011
Re: How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gearCathy B Moelans, Paul J van Diest
Journal of Clinical Pathology|April 16, 2021
Blunt duct adenosis: a separate entity from columnar cell lesions?Mirthe de Boer, Paul J van Diest
Journal of Clinical Pathology|October 28, 2011
HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?Cathy B Moelans, Paul J van Diest
The American Journal of Surgical Pathology|January 21, 2014
Serous carcinogenesis: a classic causality dilemma or which came first... ?Jonathan G Bijron, Paul J Van Diest
Journal of Clinical Pathology|January 15, 2014
CEP17 copy number increase does not indicate polysomy 17Cathy B Moelans, Paul J van Diest
Virchows Archiv : an International Journal of Pathology|November 15, 2022
Dimorphic cells: a common feature throughout the low nuclear grade breast neoplasia spectrumMirthe de Boer, Paul J van Diest
European Heart Journal|May 17, 2021
Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis?Mitko Veta, Paul J van Diest, Aryan Vink
The Journal of Pathology|February 3, 2005
Re: Clarke et al. Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotypeWerner Böcker, Paul J van Diest, Horst Bürger
Pageof 56

Showing results (1-10 of 557) with videos related to

Sort By:
Pageof 56
BMJ (Clinical Research Ed.)|September 21, 2002
No consent should be needed for using leftover body material for scientific purposes. ForPaul J van Diest
The American Journal of Surgical Pathology|January 13, 2015
Brief fixation and hormone receptor expression in breast cancer: authors' replyShona Kalkman, Paul J van Diest
Journal of the National Cancer Institute|March 17, 2011
Re: How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gearCathy B Moelans, Paul J van Diest
Journal of Clinical Pathology|April 16, 2021
Blunt duct adenosis: a separate entity from columnar cell lesions?Mirthe de Boer, Paul J van Diest
Journal of Clinical Pathology|October 28, 2011
HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?Cathy B Moelans, Paul J van Diest
The American Journal of Surgical Pathology|January 21, 2014
Serous carcinogenesis: a classic causality dilemma or which came first... ?Jonathan G Bijron, Paul J Van Diest
Journal of Clinical Pathology|January 15, 2014
CEP17 copy number increase does not indicate polysomy 17Cathy B Moelans, Paul J van Diest
Virchows Archiv : an International Journal of Pathology|November 15, 2022
Dimorphic cells: a common feature throughout the low nuclear grade breast neoplasia spectrumMirthe de Boer, Paul J van Diest
European Heart Journal|May 17, 2021
Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis?Mitko Veta, Paul J van Diest, Aryan Vink
The Journal of Pathology|February 3, 2005
Re: Clarke et al. Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotypeWerner Böcker, Paul J van Diest, Horst Bürger
Pageof 56